• Publications
  • Influence
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.
OBJECTIVE To provide a single source for the best available estimates of the national prevalence of arthritis in general and of selected musculoskeletal disorders (osteoarthritis, rheumatoidExpand
  • 2,598
  • 115
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.
OBJECTIVE To provide a single source for the best available estimates of the US prevalence of and number of individuals affected by osteoarthritis, polymyalgia rheumatica and giant cell arteritis,Expand
  • 4,459
  • 100
  • PDF
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.
Criteria for the classification of giant cell (temporal) arteritis were developed by comparing 214 patients who had this disease with 593 patients with other forms of vasculitis. For the traditionalExpand
  • 1,878
  • 73
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.
Criteria for the classification of Wegener's granulomatosis (WG) were developed by comparing 85 patients who had this disease with 722 control patients with other forms of vasculitis. For theExpand
  • 1,653
  • 55
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).
Criteria for the classification of Churg-Strauss syndrome (CSS) were developed by comparing 20 patients who had this diagnosis with 787 control patients with other forms of vasculitis. For theExpand
  • 1,708
  • 54
Polymyalgia rheumatica and giant-cell arteritis.
Summary The original descriptions of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in the medical literature date back to 1888 and 1890, respectively. Classification criteria for PMRExpand
  • 417
  • 53
Nomenclature of systemic vasculitides. Proposal of an international consensus conference.
The following are some of the conclusions and proposals made at the Chapel Hill Consensus Conference on the Nomenclature of Systemic Vasculitis. 1. Although not a prerequisite component of theExpand
  • 2,700
  • 52
Primary central nervous system vasculitis: analysis of 101 patients
To analyze the clinical findings, response to therapy, outcome, and incidence of primary central nervous system vasculitis (PCNSV) in a large cohort from a single center
  • 450
  • 48
  • PDF
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.
Criteria for the classification of Takayasu arteritis were developed by comparing 63 patients who had this disease with 744 control patients with other forms of vasculitis. Six criteria were selectedExpand
  • 1,593
  • 45
Steroid-responsive encephalopathy associated with autoimmune thyroiditis.
BACKGROUND Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), often termed Hashimoto encephalopathy, is a poorly understood and often misdiagnosed entity. OBJECTIVEExpand
  • 377
  • 35
  • PDF